![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
73
PharmaCompass offers a list of Interferon Alfa-2B API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Interferon Alfa-2B manufacturer or Interferon Alfa-2B supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Interferon Alfa-2B manufacturer or Interferon Alfa-2B supplier.
PharmaCompass also assists you with knowing the Interferon Alfa-2B API Price utilized in the formulation of products. Interferon Alfa-2B API Price is not always fixed or binding as the Interferon Alfa-2B Price is obtained through a variety of data sources. The Interferon Alfa-2B Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Interferon alpha-2b, Recombinant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Interferon alpha-2b, Recombinant, including repackagers and relabelers. The FDA regulates Interferon alpha-2b, Recombinant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Interferon alpha-2b, Recombinant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Interferon alpha-2b, Recombinant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Interferon alpha-2b, Recombinant supplier is an individual or a company that provides Interferon alpha-2b, Recombinant active pharmaceutical ingredient (API) or Interferon alpha-2b, Recombinant finished formulations upon request. The Interferon alpha-2b, Recombinant suppliers may include Interferon alpha-2b, Recombinant API manufacturers, exporters, distributors and traders.
click here to find a list of Interferon alpha-2b, Recombinant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Interferon alpha-2b, Recombinant DMF (Drug Master File) is a document detailing the whole manufacturing process of Interferon alpha-2b, Recombinant active pharmaceutical ingredient (API) in detail. Different forms of Interferon alpha-2b, Recombinant DMFs exist exist since differing nations have different regulations, such as Interferon alpha-2b, Recombinant USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Interferon alpha-2b, Recombinant DMF submitted to regulatory agencies in the US is known as a USDMF. Interferon alpha-2b, Recombinant USDMF includes data on Interferon alpha-2b, Recombinant's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Interferon alpha-2b, Recombinant USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Interferon alpha-2b, Recombinant suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Interferon alpha-2b, Recombinant Drug Master File in Japan (Interferon alpha-2b, Recombinant JDMF) empowers Interferon alpha-2b, Recombinant API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Interferon alpha-2b, Recombinant JDMF during the approval evaluation for pharmaceutical products. At the time of Interferon alpha-2b, Recombinant JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Interferon alpha-2b, Recombinant suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Interferon alpha-2b, Recombinant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Interferon alpha-2b, Recombinant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Interferon alpha-2b, Recombinant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Interferon alpha-2b, Recombinant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Interferon alpha-2b, Recombinant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Interferon alpha-2b, Recombinant suppliers with NDC on PharmaCompass.
Interferon alpha-2b, Recombinant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Interferon alpha-2b, Recombinant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Interferon alpha-2b, Recombinant GMP manufacturer or Interferon alpha-2b, Recombinant GMP API supplier for your needs.
A Interferon alpha-2b, Recombinant CoA (Certificate of Analysis) is a formal document that attests to Interferon alpha-2b, Recombinant's compliance with Interferon alpha-2b, Recombinant specifications and serves as a tool for batch-level quality control.
Interferon alpha-2b, Recombinant CoA mostly includes findings from lab analyses of a specific batch. For each Interferon alpha-2b, Recombinant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Interferon alpha-2b, Recombinant may be tested according to a variety of international standards, such as European Pharmacopoeia (Interferon alpha-2b, Recombinant EP), Interferon alpha-2b, Recombinant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Interferon alpha-2b, Recombinant USP).